Biocorrx (OTCMKTS:BICX) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Biocorrx (OTCMKTS:BICX) released its earnings results on Friday. The company reported ($0.03) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.02, Zacks reports. The company had revenue of $0.09 million during the quarter, compared to analysts’ expectations of $0.24 million.

Biocorrx Trading Down 45.7%

Shares of BICX opened at $0.15 on Friday. Biocorrx has a twelve month low of $0.15 and a twelve month high of $1.28. The firm has a market capitalization of $4.52 million, a P/E ratio of -0.95 and a beta of 0.19. The stock’s fifty day simple moving average is $0.32 and its 200 day simple moving average is $0.35.

Biocorrx Company Profile

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.